grants_govRFA-AI-27-016
Open
Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)
- Response deadline
- Jul 10, 2026 Closed
- Date posted
- May 4, 2026
- Source
- Open notice
Description
The purpose of this notice of funding opportunity (NOFO) is to support applications for the Tuberculosis (TB) Research Advancement Centers (TRACs) program. The goal of the TRACs is to develop the next generation of TB researchers and to catalyze multidisciplinary and innovative TB science by providing expertise and resources to facilitate basic and clinical TB research.
Classifications
- NAICS93.855
Documents (1)
- DownloadRFA-AI-27-016-Full-Announcement.htmltext/html;charset=UTF-8151 KB
Contacts
Similar contracts
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)Due Nov 10, 2026
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)Due Nov 10, 2026
- Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)Due Jul 7, 2028
- Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)Due Sep 24, 2026
- Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed)Due Jul 1, 2028
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)Due Jul 5, 2029